Skip to main content
LTRN
NASDAQ Life Sciences

USPTO Allows Lantern Pharma's LP-284 Method Patent for Aggressive B-Cell Lymphomas

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.479
Mkt Cap
$19.176M
52W Low
$1.11
52W High
$4.703
52W Position info
33% above low
Off High info
69% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

LTRN sits 33% above its 52-week low of $1.11.

Summary

Lantern Pharma received a USPTO Notice of Allowance for a method-of-treatment patent covering LP-284 in mantle cell lymphoma, double-hit lymphoma, and other blood cancers. The allowed claims include monotherapy and combination use with several drug classes, plus intravenous and intraperitoneal delivery. This extends LP-284's IP protection to 2042, building on existing composition-of-matter patents. The news strengthens the commercial outlook for LP-284, which is in Phase 1 trials and has shown a complete metabolic response in a heavily pretreated DLBCL patient. The company faces a going concern warning, so this patent milestone is a meaningful positive for its lead asset.

At the time of this announcement, LTRN was trading at $1.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $19.2M. The 52-week trading range was $1.11 to $4.70. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

LTRN - Latest Insights

LTRN
Nov 18, 2026, 8:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.3724
Real-time Price: $0.330 info
Change: -$0.0424 (-11%) info
Market Cap: $4.51M info
LTRN
Nov 18, 2026, 7:35 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3724
Real-time Price: $0.330 info
Change: -$0.0424 (-11%) info
Market Cap: $4.51M info
LTRN
Nov 17, 2026, 4:25 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.365
Real-time Price: $0.330 info
Change: -$0.035 (-10%) info
Market Cap: $4.51M info
LTRN
Oct 08, 2026, 4:05 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.830
Real-time Price: $0.330 info
Change: -$0.500 (-60%) info
Market Cap: $4.51M info
LTRN
Oct 07, 2026, 8:31 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.950
Real-time Price: $0.330 info
Change: -$0.620 (-65%) info
Market Cap: $4.51M info